CIAM
ISPC icon

Caitong International Asset Management’s iSpecimen ISPC Stock Holding History

Caitong International Asset Management’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Buy
+2
New +$8 ﹤0.01% 2736

Other funds holding ISPC

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Caitong International Asset Management's ISPC Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in iSpecimen (ISPC) in Q2 2026: 2 shares worth $5. The stake represents ﹤0.01% of the portfolio and ranks #2736 among its holdings.

8 funds tracked by Wall St. Rank hold ISPC as of Q2 2026.

  • Caitong International Asset Management held 2 shares of iSpecimen worth $5 as of Q2 2026.
  • iSpecimen was a new Caitong International Asset Management position in Q2 2026.
  • iSpecimen made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2736 holding.
  • 8 funds tracked by Wall St. Rank held iSpecimen as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.